Dr Reddy's Laboratories has launched Cefixime for oral suspension in the US market
: Drug firm Dr Reddy's Laboratories on Monday said it has launched Cefixime for oral suspension, used for treatment of bacterial infections, in the American market. The company has launched Cefixime for oral suspension, USP in the strengths of 100 mg/5mL and 200 mg/5mL, after getting approval from the United States Food and Drug Administration (FDA), Dr Reddy's Laboratories said in a filing to the Bombay Stock Exchange (BSE). The product is a generic version of Astellas Pharma Inc's Suprax for oral suspension, it added.
The Suprax brand and generic had US sales of around $50.5 million MAT for the most recent 12 months ending in June 2017 according to IMS Health, Dr Reddy's said.
At 2:35 pm, shares in Dr Reddy's Laboratories were trading 1.68 per cent lower at Rs 2,052.80 apiece on the BSE, whose benchmark Sensex index was up 0.49 per cent.
Election Results for Lok Sabha Election 2019 will be out on May 23. Get the latest election news and live updates on ndtv.com/elections. Catch all the action on NDTV Live. Like us on Facebook or follow us on Twitter and Instagram for news updates from each of the 543 parliamentary seats for the election 2019